Literature DB >> 27155549

Cardioprotective effects of salidroside on myocardial ischemia-reperfusion injury in coronary artery occlusion-induced rats and Langendorff-perfused rat hearts.

Xiayun Chang1, Kai Zhang2, Rui Zhou1, Fen Luo1, Lingpeng Zhu1, Jin Gao1, He He1, Tingting Wei1, Tianhua Yan3, Chunhua Ma1.   

Abstract

BACKGROUND/
OBJECTIVES: The current study was designed to investigate the protective role of salisroside on rats through the study of energy metabolism homeostasis and inflammation both in ex vivo and in vivo.
METHODS: Energy metabolism homeostasis and inflammation injury were respectively assessed in global ischemia of isolated hearts and coronary artery ligated rats.
RESULTS: Excessive release of cardiac enzymes and pro-inflammatory cytokines was inhibited by salidroside in coronary artery occlusion-induced rats. ST segment was also restored with the treatment of salidroside. Triphenyltetrazolium chloride staining (TTC) staining and pathological analysis showed that salidroside could significantly alleviate myocardial injury in vivo. Accumulated data in ex vivo indicated that salidroside improved heart function recovery, which was reflected by enhanced myocardial contractility and coronary flow in isolated hearts. The contents of ATP and glycogen both in ex vivo and in vivo were restored by salidroside compared with those in the model group. Besides, the expressions of p-AMPK, PPAR-α and PGC-1α in rats and isolated hearts subjected to salidroside were significantly elevated, while the levels of p-NF-κBp65, p-IκBα, p-IKKα and p-IKKβ were dramatically reduced by salidroside.
CONCLUSIONS: The present study comprehensively elaborated the protective effects of salidroside on myocardial injury and demonstrated that AMPK/PGC-1α and AMPK/NF-κB signaling cascades were implicated in the myocardial ischemia-reperfusion injury (I/R) model.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AMPK/NF-κB; AMPK/PGC-1α; Energy metabolism; Inflammation; Myocardial ischemia–reperfusion; Salidroside

Mesh:

Substances:

Year:  2016        PMID: 27155549     DOI: 10.1016/j.ijcard.2016.04.108

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  Protection of Myocardial Ischemia-Reperfusion by Therapeutic Hypercapnia: a Mechanism Involving Improvements in Mitochondrial Biogenesis and Function.

Authors:  Laiting Chi; Nan Wang; Wanchao Yang; Qi Wang; Dengming Zhao; Tian Sun; Wenzhi Li
Journal:  J Cardiovasc Transl Res       Date:  2019-04-12       Impact factor: 4.132

Review 2.  Mechanisms of Myocardial Damage Due to Hyperlipidemia: A Review of Recent Studies.

Authors:  Zhiqi Zhang; Hongyi Wu; Tao Wang; Yao Liu; Chun Meng
Journal:  Med Sci Monit       Date:  2022-09-16

3.  Retracted Article: Chrysin attenuates myocardial ischemia-reperfusion injury by inhibiting myocardial inflammation.

Authors:  Jingguo Wu; Nan Xun; Yang Yang; Lijin Zeng; Zhenyu Li; Wen Yang; Yanbing Liang; Hao Tang; Zhongfu Ma
Journal:  RSC Adv       Date:  2018-04-12       Impact factor: 4.036

Review 4.  Advances in Research on Anticancer Properties of Salidroside.

Authors:  An-Qi Sun; Xiu-Lian Ju
Journal:  Chin J Integr Med       Date:  2020-03-06       Impact factor: 1.978

5.  Salidroside protects the cardiac function of exhausted rats by inducing Nrf2 expression.

Authors:  Peng Xu; Yang Wang; Weiwei Sun; Yawei Sun; Wei Lu; Yumei Chang; Zheng Ping; Yang Li; Xuebin Cao
Journal:  Cardiovasc J Afr       Date:  2019-10-02       Impact factor: 1.167

6.  MiR-23a Is Involved in Myocardial Ischemia/Reperfusion Injury by Directly Targeting CX43 and Regulating Mitophagy.

Authors:  Lina Wang; Qing Li; Jiayu Diao; Lin Lin; Jin Wei
Journal:  Inflammation       Date:  2021-03-02       Impact factor: 4.092

7.  Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia.

Authors:  Xiangrong Liu; Shaohong Wen; Feng Yan; Kuan Liu; Liqiang Liu; Lei Wang; Shangfeng Zhao; Xunming Ji
Journal:  J Neuroinflammation       Date:  2018-02-09       Impact factor: 8.322

8.  Glycyrrhizic acid ameliorates myocardial ischemic injury by the regulation of inflammation and oxidative state.

Authors:  Chongli Xu; Caihong Liang; Weixin Sun; Jiandong Chen; Xiaohu Chen
Journal:  Drug Des Devel Ther       Date:  2018-05-18       Impact factor: 4.162

Review 9.  Modulatory Effects of Chinese Herbal Medicines on Energy Metabolism in Ischemic Heart Diseases.

Authors:  Fanghe Li; Jinmao Li; Saisai Li; Shuwen Guo; Ping Li
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

10.  Curcumin attenuates myocardial ischemia-reperfusion injury.

Authors:  Kun Liu; Honglin Chen; Qing-Sheng You; Qing Ye; Fei Wang; Shuo Wang; Shuang-Long Zhang; Kang-Jun Yu; Qi Lu
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.